Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Future Medicinal Chemistry
|
September 15, 2025
Design and synthesis of novel 3,5-diphenyl pyrazolines acting as potent EGFR inhibitors with off-target antileukemic effect
Basma S Gabr, Abdelrahman R Shalabi, Mona F Said, et al.
Future Medicinal Chemistry
|
January 31, 2024
Exploring new imines as anti-inflammatory COX and 5-LOX inhibitors with an improved pharmacokinetic profile
Mona F Said, Bahia A Moussa, Marianne A Mahrouse, et al.
Future Medicinal Chemistry
|
April 18, 2024
Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation
Mona F Said, Sarah M Marie, Nada M Mohamed, et al.
Journal De Medecine Vasculaire
|
September 2, 2022
Predicting the risk of recurrent venous thromboembolism: Impact and therapeutic consequences of inherited thrombophilia
H Baccouche, M Belhadj, F Said, et al.
Leukemia
|
November 1, 1989
Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid
R E Gallagher, F Said, I Pua, et al.
European Journal of Medicinal Chemistry
|
September 25, 2023
Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors
Rehab F Ahmed, Walaa R Mahmoud, Nagwa M Abdelgawad, et al.
Future Medicinal Chemistry
|
January 30, 2024
Investigations of new <i>N</i>-substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity
Mona F Said, Riham F George, Walid Fayed, et al.
Bioorganic Chemistry
|
August 14, 2021
Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity
Peter A Halim, Hanan H Georgey, Mina Y George, et al.
Future Medicinal Chemistry
|
April 11, 2017
Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
Hassanein H Hassanein, Hanan H Georgey, Marwa A Fouad, et al.
Molecular Diversity
|
November 11, 2024
Insight on novel sulfamoylphenyl pyrazole derivatives as anticancer carbonic anhydrase inhibitors
Rehab F Ahmed, Walaa R Mahmoud, Nagwa M Abdelgawad, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Future Medicinal Chemistry
|
September 15, 2025
Design and synthesis of novel 3,5-diphenyl pyrazolines acting as potent EGFR inhibitors with off-target antileukemic effect
Basma S Gabr, Abdelrahman R Shalabi, Mona F Said, et al.
Future Medicinal Chemistry
|
January 31, 2024
Exploring new imines as anti-inflammatory COX and 5-LOX inhibitors with an improved pharmacokinetic profile
Mona F Said, Bahia A Moussa, Marianne A Mahrouse, et al.
Future Medicinal Chemistry
|
April 18, 2024
Insight on novel oxindole conjugates adopting different anti-inflammatory investigations and quantitative evaluation
Mona F Said, Sarah M Marie, Nada M Mohamed, et al.
Journal De Medecine Vasculaire
|
September 2, 2022
Predicting the risk of recurrent venous thromboembolism: Impact and therapeutic consequences of inherited thrombophilia
H Baccouche, M Belhadj, F Said, et al.
Leukemia
|
November 1, 1989
Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid
R E Gallagher, F Said, I Pua, et al.
European Journal of Medicinal Chemistry
|
September 25, 2023
Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors
Rehab F Ahmed, Walaa R Mahmoud, Nagwa M Abdelgawad, et al.
Future Medicinal Chemistry
|
January 30, 2024
Investigations of new <i>N</i>-substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activity
Mona F Said, Riham F George, Walid Fayed, et al.
Bioorganic Chemistry
|
August 14, 2021
Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity
Peter A Halim, Hanan H Georgey, Mina Y George, et al.
Future Medicinal Chemistry
|
April 11, 2017
Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
Hassanein H Hassanein, Hanan H Georgey, Marwa A Fouad, et al.
Molecular Diversity
|
November 11, 2024
Insight on novel sulfamoylphenyl pyrazole derivatives as anticancer carbonic anhydrase inhibitors
Rehab F Ahmed, Walaa R Mahmoud, Nagwa M Abdelgawad, et al.
Page
of 6